Cinarzin 15mg 10pcs

Indications of Cinarzin 15

It is primarily used to treat the symptoms of nausea and vertigo associated with Meniere's disease and other labyrinthine abnormalities, as well as to prevent and treat motion sickness. It's also used to treat a variety of vascular problems.

Circulatory problems in the brain:

Dizziness, ear buzzing (tinnitus), vascular headache, unsociability and irritability, fatigue, sleep rhythm disorders such as premature awakening, involutional depressions, loss of memory and lack of concentration, incontinence, and other aging-related disorders are treated with prophylaxis and maintenance therapy.

Aftereffects of cranial and brain trauma.

Post-apoplectic disorders are a kind of post-apoplectic syndrome.

Migraine.

Symptoms of vascular spasms and arteriosclerosis (obliterating arteritis, thromboangitis obliterans, Raynaud's disease, diabetes, acrocyanosis, perrio, etc.) such as intermittent claudication, trophic disturbances, pregangrene, trophic and varicose ulcers, paraesthesia, nocturnal cramps, cold extremities are treated with prophylaxis.

Balance problems include:

Symptoms of labyrinthine arteriosclerosis, vestibular irritability, and Meniere's syndrome, such as vertigo, dizziness, giddiness, syncopal episodes, tinnitus, nystagmus, nausea, and vomiting, are treated with prophylaxis and maintenance therapy.

Motion sickness prevention.

Pharmaceutical Name of Cinarzin 15

Ibn Sina Pharmaceuticals Ltd.

Pharmacology

Cinnarizine is a peripheral antivasoconstrictor, antihistamine, and labyrinthine sedative. Cinnarizine is a calcium antagonist that inhibits the intracellular inflow of Ca2+. By inhibiting Ca2+ influx through smooth muscle calcium channels, it prevents Ca2+-dependent contraction of arterial smooth muscle, improving vestibular symptoms and preventing peripheral arterial disease.

Dosage & Administration

Adults should take 15 to 30 mg three times a day.

Half the adult dosage for children (5 to 12 years).

A dosage of 30 mg two hours prior to the commencement of the travel and 15 mg every eight hours during the journey is recommended for motion sickness.

75 mg twice or three times day for peripheral arterial disease.

Interaction of Cinarzin 15

Cinnarizine has not been found to interact with antihypertensives, diuretics, anticoagulants, or hypoglycaemics when taken together.

Contraindications

There are no known contraindications to using this product. It has been discovered to dramatically lower blood pressure. In hypotensive individuals, however, the medication should be taken with care.

Side Effects of Cinarzin 15

Side effects such as drowsiness and gastrointestinal problems are exceedingly uncommon. They are transitory and may be easily avoided by progressively attaining the appropriate dose. Rarely, allergic skin reactions and tiredness have recorded. Extrapyramidal symptoms may worsen or develop in older persons who are on long-term treatment. In such instances, the therapy should be decreased or discontinued.

Pregnancy & Lactation

Cinnarizine's safety in human pregnancy has not been proved, despite the absence of teratogenic effects in animal research. As a result, it is not recommended to use Cinnarizine during pregnancy.

Precautions & Warnings

Cinnarizine can make you drowsy, so do not drive or operate machinery if you're impacted. Avoid consuming alcoholic beverages.

Storage Conditions

Store in a cool (below 30°C) and dry place. Keep away from light and out of reach of children.